Novabay Pharmaceuticals Total Liabilities

Novabay Pharmaceuticals (NBY) currently reports a total liabilities of $270K as of June 2026. That compares with $2.7M in the prior-year period — down 89.9% year over year. Use the charts on this page to explore Novabay Pharmaceuticals's total liabilities history and peer comparisons.

Novabay Pharmaceuticals's total liabilities decreased from $2.7M to $270K — a 89.9% year-over-year decrease (period ending June 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Novabay Pharmaceuticals reported $270K in total liabilities as of June 2026. That compares with $2.7M in the prior-year period — down 89.9% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current total liabilities of $270K, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Novabay Pharmaceuticals, and consider following NBY for alerts when major investors trade the stock.

Novabay Pharmaceuticals is classified in the Healthcare sector. On total liabilities, it currently shows $270K. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing NBY with unrelated industries.